tiprankstipranks
Symbio Pharmaceuticals Limited (JP:4582)
:4582
Japanese Market

Symbio Pharmaceuticals Limited (4582) Ownership - Who Owns Symbio Pharmaceuticals Limited?

Compare
1 Followers

Symbio Pharmaceuticals Limited (4582) Ownership Overview

0.16%99.84%
0.16% ETFs
99.84% Public Companies and
Individual Investors
The ownership structure of Symbio Pharmaceuticals Limited (JP:4582) stock is a mix of institutional, retail, and individual investors. , and 99.84% is owned by Public Companies and Individual Investors.
The ownership structure of Symbio Pharmaceuticals Limited (JP:4582) stock is a mix of institutional, retail, and individual investors. , 0.16% is owned by Insiders

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
60,200Institution0.13%73,504
11,500Institution0.03%14,042

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
36,600Institution0.08%44,933
23,600Institution0.05%28,973
11,500Institution0.03%14,118

FAQ

Who Owns Symbio Pharmaceuticals Limited (JP:4582)?
Currently, no data Available
What percentage of Symbio Pharmaceuticals Limited (JP:4582) stock is held by institutional investors?
Currently, no data Available
What percentage of Symbio Pharmaceuticals Limited (JP:4582) stock is held by retail investors?
According to the latest TipRanks data, approximately 99.84% of Symbio Pharmaceuticals Limited (JP:4582) stock is held by retail investors.
    Who owns the most shares of Symbio Pharmaceuticals Limited (JP:4582)?
    SPDR owns the most shares of Symbio Pharmaceuticals Limited (JP:4582).
      What is the significance of the ownership structure for a publicly traded company?
      The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis